AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Learn about gas rewards cards that do not charge an annual fee. Enjoy savings on your gas purchases.
26,909 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
As AI fuels data growth, Silicon Motion Technology stands out in the memory controller niche. This article breaks dow...
As Salesforce unveils a strategic acquisition, investors are asking whether this move can truly beat the current SaaS...
If the idea of Cathie Wood buying million-dollar stakes catches your eye, you’re not alone. This article breaks down ...
NexaTech Holdings, a $40 billion market-cap company, raised its revenue guidance on stronger-than-expected demand, si...
Shopify delivered strong quarterly results, but the stock traded lower as guidance softened. This article explains wh...
Archer’s Q1 2026 numbers set the tone for the year. This article breaks down the earnings call, explains what really ...
Rocket Lab stock has hit an all-time high, but savvy investors know a rally is more than a headline. This guide break...
Nearly 40% of Stanford undergraduates are registered with disability services, a surge linked to broader Gen Z trends...
Intel faces a pivotal moment as Q1 losses mount and cash burn deepens. Analysts and investors debate buy, hold sell i...
Quantum hype is real, but practical gains arrive faster from AI-driven platforms and strong cash flow. This piece exp...
Drones and government funding chatter are reshaping investor sentiment. Ondas is at the center of the action, with ot...